Evaluation of colistin dose in chronic intermittent dialysis patients: a population pharmacokinetics approach

被引：0
|
作者：
Marsot, A. [1 ]
Lebrun, G. [2 ]
Boulamery, A. [1 ]
Jaubert, D. [2 ]
Brunet, P. [2 ]
Bruguerolle, B. [1 ]
Simon, N. [1 ]
机构：
[1] Hop Enfants La Timone, APHM, Serv Pharmacol Clin, Marseille, France
[2] Hop Conception, APHM, Ctr Nephrol & Transplantat Renale, Marseille, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2013年 / 27卷
关键词：
colistin; pharmacokinetics; modelling; dialysis patients;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients
    Peng, LW
    Lien, YHH
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) : 162 - 166
  • [42] Correction to: Population pharmacokinetics‑pharmacodynamics of fondaparinux in dialysis‑dependent chronic kidney disease patients undergoing chronic renal replacement therapy
    Danica Michaličková
    Jan Miroslav Hartinger
    Zuzana Hladinová
    Vladimíra Bednářová
    Barbora Szonowská
    Vladimír Polakovič
    Andreas Matthios
    Vladimír Tesař
    Ondřej Slanař
    Elke H. J. Krekels
    European Journal of Clinical Pharmacology, 2022, 78 : 99 - 99
  • [43] Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria
    Kristoffersson, A. N.
    Rognas, V
    Brill, M. J. E.
    Dishon-Benattar, Y.
    Durante-Mangoni, E.
    Daitch, V
    Skiada, A.
    Lellouche, J.
    Nutman, A.
    Kotsaki, A.
    Andini, R.
    Eliakim-Raz, N.
    Bitterman, R.
    Antoniadou, A.
    Karlsson, M. O.
    Theuretzbacher, U.
    Leibovici, L.
    Daikos, G. L.
    Mouton, J. W.
    Carmeli, Y.
    Paul, M.
    Friberg, L. E.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (12) : 1644 - 1650
  • [44] Commentary: Population pharmacokinetics of colistin sulfate in critically ill patients: Exposure and clinical efficacy
    Chen, Huadong
    Li, Piaopiao
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [45] EARLY DETECTION OF PERITONITIS IN PATIENTS ON CHRONIC INTERMITTENT PERITONEAL-DIALYSIS
    FRAGOLA, JA
    BREGMAN, H
    KIDNEY INTERNATIONAL, 1983, 23 (01) : 148 - 148
  • [46] ERYTHROCYTE SODIUM AND POTASSIUM IN PATIENTS ON CHRONIC INTERMITTENT PERITONEAL-DIALYSIS
    CHENG, JT
    FEINFELD, DA
    HOTCHKISS, J
    NURSE, H
    BRISCOE, A
    THOMSON, GE
    CLINICAL RESEARCH, 1985, 33 (03): : A769 - A769
  • [47] CHRONIC INTERMITTENT PERITONEAL-DIALYSIS IN HIGH-RISK PATIENTS
    KRAMER, W
    GROSSMANN, R
    TAUFERTSHOFER, U
    SCHMIDT, U
    HERBIG, W
    ALBERT, FW
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1986, 15 (11) : 473 - 474
  • [48] EVALUATION OF INTRAVENOUS AND INTRAPERITONEAL PHARMACOKINETICS OF DALBAVANCIN IN PERITONEAL DIALYSIS PATIENTS
    Van Matre, Edward
    Teitelbaum, Isaac
    Kiser, Tyree
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 235 - 235
  • [49] EVALUATION OF LOW FLOW LONG DWELL CHRONIC INTERMITTENT PERITONEAL-DIALYSIS
    DOODY, PT
    GOLDBERG, M
    CLINICAL AND EXPERIMENTAL DIALYSIS AND APHERESIS, 1982, 6 (01): : 45 - 51
  • [50] Serum Hepcidin Evaluation in Patients with Chronic Dialysis
    Manolov, V.
    Yonova, D.
    Vazelov, E.
    Bogov, B.
    Velizarova, M.
    Atanasova, B.
    Vasilev, V.
    Tzatchev, K.
    Bogov, I.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2015, 5 (02) : 76 - 78
12345